The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against ESSA Pharma Inc. — Neutral
EPIX Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 12, 2023 and October 31, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 25, 2025.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Integral Ad Science Holding Corp. — Neutral
IAS Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 2, 2023, and February 27, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.
NVO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Stockholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
NVO Accesswire — February 25, 2025NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Novo Nordisk securities between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period").
S&P Global's (SPGI 0.30%) stock has rallied more than 80% over the past five years and is currently hovering near its all-time high. The financial services leader impressed investors with its robust growth and resistance to macro headwinds, and it could maintain that momentum as the macro environment warms up again.
A Securities Fraud Lawsuit Has Been Filed Against Neumora Therapeutics, Inc. And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
NMRA Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ:NMRA) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on September 15, 2023, are encouraged to contact the firm before April 7, 2025.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Edison International — Neutral
EIX Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edison International ("Edison" or "the Company") (NYSE:EIX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 25, 2021 and February 6, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.
An Investigation Has Been Launched Into JinkoSolar Holding Co., Ltd. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
JKS Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of JinkoSolar Holding Co., Ltd. ("JinkoSolar" or "the Company") (NYSE:JKS) for violations of the securities laws.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against GSK plc — Neutral
GSK Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE:GSK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2020 and August 14, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.
An Investigation Has Been Launched Into Flex Ltd. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
FLEX Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Flex Ltd. ("Flex" or "the Company") (NASDAQ:FLEX) for violations of the securities laws.
A Securities Fraud Lawsuit Has Been Filed Against FMC Corporation And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
FMC Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 16, 2023 and February 4, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.
A Securities Fraud Lawsuit Has Been Filed Against Intellia Therapeutics, Inc. And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
NTLA Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ:NTLA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.
An Investigation Has Been Launched Into STAAR Surgical Company For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
STAA Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ:STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Investigation Has Been Launched Into Harmonic Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
HLIT Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Harmonic Inc. ("Harmonic" or "the Company") (NASDAQ:HLIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Investigation Has Been Launched Into Olin Corporation For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
OLN Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Olin Corporation ("Olin" or "the Company") (NYSE:OLN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Alarum Technologies Ltd. — Neutral
ALAR Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alarum Technologies Ltd. ("Alarum" or "the Company") (NASDAQ:ALAR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
An Investigation Has Been Launched Into Quanterix Corporation For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
QTRX Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Investigation Has Been Launched Into Huntington Ingalls Industries, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
HII Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. ("Huntington Ingalls" or "the Company") (NYSE:HII) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.
Investors in Constellation Brands, Inc. Should Contact Levi & Korsinsky Before April 21, 2025 to Discuss Your Rights - STZ — Neutral
STZ Accesswire — February 25, 2025NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your Constellation Brands, Inc. (NYSE:STZ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/constellation-brands-inc-lawsuit-submission-form?prid=132066&wire=1 or contact Joseph E. Levi, Esq.
Micron Technology, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MU — Neutral
MU Accesswire — February 25, 2025NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=132068&wire=1 or contact Joseph E. Levi, Esq.
The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation — Neutral
MEDP Accesswire — February 25, 2025LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
